Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA to Revise Its FY2004-2008 Business Plan in March
March 5, 2007
- Otsuka to Gear Up Promotion of Abilify
March 5, 2007
- REGULATORY NEWS IN BRIEF
March 5, 2007
- Mochida Joins Novartis to Promote Diovan
March 5, 2007
- Prefectures Generally Unenthusiastic about Promoting Use of Generics
March 5, 2007
- Vesicare Leads Market for Pollakisuria, Urinary Incontinence
March 5, 2007
- Ohara Pharm. Aims for Sales of \10 Bil. in FY2009
March 5, 2007
- Approval of Western Herbs as OTC Drugs Becoming Reality: JSMI
March 5, 2007
- SELF-MEDICATION NEWS IN BRIEF
March 5, 2007
- OPINION／Global Thinkers Wanted in a World of Change
March 5, 2007
- Japan's Total Healthcare Expenditure Is One of the Lowest among OECD Member Countries: JMA
March 5, 2007
- IT Grand Design Drafted by Korosho
March 5, 2007
- BUSINESS NEWS IN BRIEF
March 5, 2007
- More Radiologists, Radiotherapy Equipment Specialists Needed: Prof. Nakagawa
March 5, 2007
- Kowa, Kowa Pharmaceuticals to Integrate R&D, Production Functions
March 5, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 5, 2007
- PotelligentTM Technology Licensed to 8 Companies: BioWa
March 5, 2007
- SEMINAR
March 5, 2007
- Adiponectin, an Important Etiological Factor for Diabetes: Prof. Kadowaki
March 5, 2007
- TOPICS 2 articles
March 5, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…